Our cyber incident response app has just undergone a major upgrade! - Find out more

Article June 15, 2020

Exposures during the research & development lifecycle

Find out about the exposures that biotechs and service organizations face during the R&D process


There are many types of life science companies involved in the research and development (R&D) of new drugs and medical devices, but they generally fall into two camps, biotechnology firms that develop the drug or device, and service organizations who help bring those products to market.

The exposures that biotechs and service organizations face will evolve throughout the R&D process, and how quickly each company moves through this journey will depend on their individual product but can take anywhere from a few months to a few years.

We’ve outlined the phases of the R&D process to help you talk to your life science clients about the key exposures they face they discover, develop and test their products.